Global Conjunctivitis Sales Market Report 2023

Publisher Name :
Date: 03-Jan-2023
No. of pages: 119
Inquire Before Buying

Conjunctivitis, or inflammation of the conjunctiva, is a general term that refers to a diverse group of diseases/disorders that affect the conjunctiva primarily. Most varieties of conjunctivitis are self-limited, but some progress and may cause serious ocular and extraocular complications.

Conjunctivitis is more commonly referred to as pink eye. The whites of the eyes appear pink or red when the conjunctiva (the transparent membrane which lines part of the eyeball) becomes inflamed or infected.

Market Analysis and Insights: Global Conjunctivitis Market

Due to the COVID-19 pandemic, the global Conjunctivitis market size is estimated to be worth US$ 3560.1 million in 2022 and is forecast to a readjusted size of US$ 3983.8 million by 2029 with a CAGR of 1.6% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Antibiotic accounting for % of the Conjunctivitis global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Newborns segment is altered to an % CAGR throughout this forecast period.

The technical barriers of conjunctivitis industry are existed apparently. The key technology and higher level products are in the hand of the global leading enterprise like Novartis, Santen Pharmaceutical, Bausch + Lomb, Allergan, Sun Pharmaceutical, Akorn and Sinqi, etc.

Global Conjunctivitis Scope and Market Size

The global Conjunctivitis market is segmented by company, region (country), type and end user. Players, stakeholders, and other participants in the global Conjunctivitis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and end user for the period 2018-2029.

Segment by Type

- Antibiotic

- Pills

- Ointment

Segment by End User

- Newborns

- Children

- Adults

By Region

- United States

- Europe

- China

- Japan

- Southeast Asia

- India

- Other Regions

By Company

- Novartis (CH)

- Santen Pharmaceutical (JP)

- Bausch & Lomb (US)

- Allergan (US)

- Sun Pharmaceutical (ID)

- Akorn (US)

- Freda (CN)

- Sinqi (CN)

- Univision (CN)

Global Conjunctivitis Sales Market Report 2023

Table of Contents
1 Conjunctivitis Market Overview
1.1 Conjunctivitis Product Scope
1.2 Conjunctivitis Segment by Type
1.2.1 Global Conjunctivitis Sales by Type (2018 & 2022 & 2029)
1.2.2 Antibiotic
1.2.3 Pills
1.2.4 Ointment
1.3 Conjunctivitis Segment by End User
1.3.1 Global Conjunctivitis Sales Comparison by End User (2018 & 2022 & 2029)
1.3.2 Newborns
1.3.3 Children
1.3.4 Adults
1.4 Conjunctivitis Market Estimates and Forecasts (2018-2029)
1.4.1 Global Conjunctivitis Market Size in Value Growth Rate (2018-2029)
1.4.2 Global Conjunctivitis Market Size in Volume Growth Rate (2018-2029)
1.4.3 Global Conjunctivitis Price Trends (2018-2029)
2 Conjunctivitis Estimates and Forecasts by Region
2.1 Global Conjunctivitis Market Size by Region: 2018 VS 2022 VS 2029
2.2 Global Conjunctivitis Retrospective Market Scenario by Region (2018-2023)
2.2.1 Global Conjunctivitis Sales Market Share by Region (2018-2023)
2.2.2 Global Conjunctivitis Revenue Market Share by Region (2018-2023)
2.3 Global Conjunctivitis Market Estimates and Forecasts by Region (2024-2029)
2.3.1 Global Conjunctivitis Sales Estimates and Forecasts by Region (2024-2029)
2.3.2 Global Conjunctivitis Revenue Forecast by Region (2024-2029)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Conjunctivitis Estimates and Projections (2018-2029)
2.4.2 Europe Conjunctivitis Estimates and Projections (2018-2029)
2.4.3 China Conjunctivitis Estimates and Projections (2018-2029)
2.4.4 Japan Conjunctivitis Estimates and Projections (2018-2029)
2.4.5 Southeast Asia Conjunctivitis Estimates and Projections (2018-2029)
2.4.6 India Conjunctivitis Estimates and Projections (2018-2029)
3 Global Conjunctivitis Competition Landscape by Players
3.1 Global Top Conjunctivitis Players by Sales (2018-2023)
3.2 Global Top Conjunctivitis Players by Revenue (2018-2023)
3.3 Global Conjunctivitis Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Conjunctivitis as of 2022)
3.4 Global Conjunctivitis Average Price by Company (2018-2023)
3.5 Manufacturers Conjunctivitis Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Conjunctivitis Market Size by Type
4.1 Global Conjunctivitis Historic Market Review by Type (2018-2023)
4.1.1 Global Conjunctivitis Sales by Type (2018-2023)
4.1.2 Global Conjunctivitis Revenue by Type (2018-2023)
4.1.3 Global Conjunctivitis Price by Type (2018-2023)
4.2 Global Conjunctivitis Market Estimates and Forecasts by Type (2024-2029)
4.2.1 Global Conjunctivitis Sales Forecast by Type (2024-2029)
4.2.2 Global Conjunctivitis Revenue Forecast by Type (2024-2029)
4.2.3 Global Conjunctivitis Price Forecast by Type (2024-2029)
5 Global Conjunctivitis Market Size by End User
5.1 Global Conjunctivitis Historic Market Review by End User (2018-2023)
5.1.1 Global Conjunctivitis Sales by End User (2018-2023)
5.1.2 Global Conjunctivitis Revenue by End User (2018-2023)
5.1.3 Global Conjunctivitis Price by End User (2018-2023)
5.2 Global Conjunctivitis Market Estimates and Forecasts by End User (2024-2029)
5.2.1 Global Conjunctivitis Sales Forecast by End User (2024-2029)
5.2.2 Global Conjunctivitis Revenue Forecast by End User (2024-2029)
5.2.3 Global Conjunctivitis Price Forecast by End User (2024-2029)
6 United States Conjunctivitis Market Facts & Figures
6.1 United States Conjunctivitis Sales by Company
6.1.1 United States Conjunctivitis Sales by Company (2018-2023)
6.1.2 United States Conjunctivitis Revenue by Company (2018-2023)
6.2 United States Conjunctivitis Sales Breakdown by Type
6.2.1 United States Conjunctivitis Sales Breakdown by Type (2018-2023)
6.2.2 United States Conjunctivitis Sales Breakdown by Type (2024-2029)
6.3 United States Conjunctivitis Sales Breakdown by End User
6.3.1 United States Conjunctivitis Sales Breakdown by End User (2018-2023)
6.3.2 United States Conjunctivitis Sales Breakdown by End User (2024-2029)
7 Europe Conjunctivitis Market Facts & Figures
7.1 Europe Conjunctivitis Sales by Company
7.1.1 Europe Conjunctivitis Sales by Company (2018-2023)
7.1.2 Europe Conjunctivitis Revenue by Company (2018-2023)
7.2 Europe Conjunctivitis Sales Breakdown by Type
7.2.1 Europe Conjunctivitis Sales Breakdown by Type (2018-2023)
7.2.2 Europe Conjunctivitis Sales Breakdown by Type (2024-2029)
7.3 Europe Conjunctivitis Sales Breakdown by End User
7.3.1 Europe Conjunctivitis Sales Breakdown by End User (2018-2023)
7.3.2 Europe Conjunctivitis Sales Breakdown by End User (2024-2029)
8 China Conjunctivitis Market Facts & Figures
8.1 China Conjunctivitis Sales by Company
8.1.1 China Conjunctivitis Sales by Company (2018-2023)
8.1.2 China Conjunctivitis Revenue by Company (2018-2023)
8.2 China Conjunctivitis Sales Breakdown by Type
8.2.1 China Conjunctivitis Sales Breakdown by Type (2018-2023)
8.2.2 China Conjunctivitis Sales Breakdown by Type (2024-2029)
8.3 China Conjunctivitis Sales Breakdown by End User
8.3.1 China Conjunctivitis Sales Breakdown by End User (2018-2023)
8.3.2 China Conjunctivitis Sales Breakdown by End User (2024-2029)
9 Japan Conjunctivitis Market Facts & Figures
9.1 Japan Conjunctivitis Sales by Company
9.1.1 Japan Conjunctivitis Sales by Company (2018-2023)
9.1.2 Japan Conjunctivitis Revenue by Company (2018-2023)
9.2 Japan Conjunctivitis Sales Breakdown by Type
9.2.1 Japan Conjunctivitis Sales Breakdown by Type (2018-2023)
9.2.2 Japan Conjunctivitis Sales Breakdown by Type (2024-2029)
9.3 Japan Conjunctivitis Sales Breakdown by End User
9.3.1 Japan Conjunctivitis Sales Breakdown by End User (2018-2023)
9.3.2 Japan Conjunctivitis Sales Breakdown by End User (2024-2029)
10 Southeast Asia Conjunctivitis Market Facts & Figures
10.1 Southeast Asia Conjunctivitis Sales by Company
10.1.1 Southeast Asia Conjunctivitis Sales by Company (2018-2023)
10.1.2 Southeast Asia Conjunctivitis Revenue by Company (2018-2023)
10.2 Southeast Asia Conjunctivitis Sales Breakdown by Type
10.2.1 Southeast Asia Conjunctivitis Sales Breakdown by Type (2018-2023)
10.2.2 Southeast Asia Conjunctivitis Sales Breakdown by Type (2024-2029)
10.3 Southeast Asia Conjunctivitis Sales Breakdown by End User
10.3.1 Southeast Asia Conjunctivitis Sales Breakdown by End User (2018-2023)
10.3.2 Southeast Asia Conjunctivitis Sales Breakdown by End User (2024-2029)
11 India Conjunctivitis Market Facts & Figures
11.1 India Conjunctivitis Sales by Company
11.1.1 India Conjunctivitis Sales by Company (2018-2023)
11.1.2 India Conjunctivitis Revenue by Company (2018-2023)
11.2 India Conjunctivitis Sales Breakdown by Type
11.2.1 India Conjunctivitis Sales Breakdown by Type (2018-2023)
11.2.2 India Conjunctivitis Sales Breakdown by Type (2024-2029)
11.3 India Conjunctivitis Sales Breakdown by End User
11.3.1 India Conjunctivitis Sales Breakdown by End User (2018-2023)
11.3.2 India Conjunctivitis Sales Breakdown by End User (2024-2029)
12 Company Profiles and Key Figures in Conjunctivitis Business
12.1 Novartis (CH)
12.1.1 Novartis (CH) Corporation Information
12.1.2 Novartis (CH) Business Overview
12.1.3 Novartis (CH) Conjunctivitis Sales, Revenue and Gross Margin (2018-2023)
12.1.4 Novartis (CH) Conjunctivitis Products Offered
12.1.5 Novartis (CH) Recent Development
12.2 Santen Pharmaceutical (JP)
12.2.1 Santen Pharmaceutical (JP) Corporation Information
12.2.2 Santen Pharmaceutical (JP) Business Overview
12.2.3 Santen Pharmaceutical (JP) Conjunctivitis Sales, Revenue and Gross Margin (2018-2023)
12.2.4 Santen Pharmaceutical (JP) Conjunctivitis Products Offered
12.2.5 Santen Pharmaceutical (JP) Recent Development
12.3 Bausch & Lomb (US)
12.3.1 Bausch & Lomb (US) Corporation Information
12.3.2 Bausch & Lomb (US) Business Overview
12.3.3 Bausch & Lomb (US) Conjunctivitis Sales, Revenue and Gross Margin (2018-2023)
12.3.4 Bausch & Lomb (US) Conjunctivitis Products Offered
12.3.5 Bausch & Lomb (US) Recent Development
12.4 Allergan (US)
12.4.1 Allergan (US) Corporation Information
12.4.2 Allergan (US) Business Overview
12.4.3 Allergan (US) Conjunctivitis Sales, Revenue and Gross Margin (2018-2023)
12.4.4 Allergan (US) Conjunctivitis Products Offered
12.4.5 Allergan (US) Recent Development
12.5 Sun Pharmaceutical (ID)
12.5.1 Sun Pharmaceutical (ID) Corporation Information
12.5.2 Sun Pharmaceutical (ID) Business Overview
12.5.3 Sun Pharmaceutical (ID) Conjunctivitis Sales, Revenue and Gross Margin (2018-2023)
12.5.4 Sun Pharmaceutical (ID) Conjunctivitis Products Offered
12.5.5 Sun Pharmaceutical (ID) Recent Development
12.6 Akorn (US)
12.6.1 Akorn (US) Corporation Information
12.6.2 Akorn (US) Business Overview
12.6.3 Akorn (US) Conjunctivitis Sales, Revenue and Gross Margin (2018-2023)
12.6.4 Akorn (US) Conjunctivitis Products Offered
12.6.5 Akorn (US) Recent Development
12.7 Freda (CN)
12.7.1 Freda (CN) Corporation Information
12.7.2 Freda (CN) Business Overview
12.7.3 Freda (CN) Conjunctivitis Sales, Revenue and Gross Margin (2018-2023)
12.7.4 Freda (CN) Conjunctivitis Products Offered
12.7.5 Freda (CN) Recent Development
12.8 Sinqi (CN)
12.8.1 Sinqi (CN) Corporation Information
12.8.2 Sinqi (CN) Business Overview
12.8.3 Sinqi (CN) Conjunctivitis Sales, Revenue and Gross Margin (2018-2023)
12.8.4 Sinqi (CN) Conjunctivitis Products Offered
12.8.5 Sinqi (CN) Recent Development
12.9 Univision (CN)
12.9.1 Univision (CN) Corporation Information
12.9.2 Univision (CN) Business Overview
12.9.3 Univision (CN) Conjunctivitis Sales, Revenue and Gross Margin (2018-2023)
12.9.4 Univision (CN) Conjunctivitis Products Offered
12.9.5 Univision (CN) Recent Development
13 Conjunctivitis Manufacturing Cost Analysis
13.1 Conjunctivitis Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Conjunctivitis
13.4 Conjunctivitis Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Conjunctivitis Distributors List
14.3 Conjunctivitis Customers
15 Market Dynamics
15.1 Conjunctivitis Industry Trends
15.2 Conjunctivitis Market Drivers
15.3 Conjunctivitis Market Challenges
15.4 Conjunctivitis Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Conjunctivitis Sales (US$ Million) Growth Rate by Type (2018 & 2022 & 2029)
Table 2. Global Conjunctivitis Sales ((US$ Million)) Comparison by End User (2018 & 2022 & 2029)
Table 3. Global Conjunctivitis Market Size (US$ Million) by Region: 2018 VS 2022 VS 2029
Table 4. Global Conjunctivitis Sales (K Units) by Region (2018-2023)
Table 5. Global Conjunctivitis Sales Market Share by Region (2018-2023)
Table 6. Global Conjunctivitis Revenue (US$ Million) Market Share by Region (2018-2023))
Table 7. Global Conjunctivitis Revenue Share by Region (2018-2023)
Table 8. Global Conjunctivitis Sales (K Units) Forecast by Region (2024-2029)
Table 9. Global Conjunctivitis Sales Market Share Forecast by Region (2024-2029)
Table 10. Global Conjunctivitis Revenue (US$ Million) Forecast by Region (2024-2029)
Table 11. Global Conjunctivitis Revenue Share Forecast by Region (2024-2029)
Table 12. Global Conjunctivitis Sales by Company (K Units) & (2018-2023)
Table 13. Global Conjunctivitis Sales Share by Company (2018-2023)
Table 14. Global Conjunctivitis Revenue by Company (US$ Million) & (2018-2023)
Table 15. Global Conjunctivitis Revenue Share by Company (2018-2023)
Table 16. Global Conjunctivitis by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Conjunctivitis as of 2022)
Table 17. Global Market Conjunctivitis Average Price by Company (USD/Unit) & (2018-2023)
Table 18. Manufacturers Conjunctivitis Manufacturing Sites and Area Served
Table 19. Manufacturers Conjunctivitis Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Conjunctivitis Sales by Type (2018-2023) & (K Units)
Table 22. Global Conjunctivitis Sales Share by Type (2018-2023)
Table 23. Global Conjunctivitis Revenue by Type (2018-2023) & (US$ Million)
Table 24. Global Conjunctivitis Price by Type (2018-2023) & (USD/Unit)
Table 25. Global Conjunctivitis Sales by Type (2024-2029)
Table 26. Global Conjunctivitis Revenue by Type (2024-2029) & (US$ Million)
Table 27. Global Conjunctivitis Revenue Share by Type (2024-2029)
Table 28. Global Conjunctivitis Price by Type (2024-2029) & (USD/Unit)
Table 29. Global Conjunctivitis Sales by End User (2018-2023) & (K Units)
Table 30. Global Conjunctivitis Sales Share by End User (2018-2023)
Table 31. Global Conjunctivitis Revenue by End User (2018-2023) & (US$ Million)
Table 32. Global Conjunctivitis Price by End User (2018-2023) & (USD/Unit)
Table 33. Global Conjunctivitis Sales by End User (2024-2029) & (K Units)
Table 34. Global Conjunctivitis Sales Share by End User (2024-2029)
Table 35. Global Conjunctivitis Revenue by End User (2024-2029) & (US$ Million)
Table 36. Global Conjunctivitis Revenue Share by End User (2024-2029)
Table 37. Global Conjunctivitis Price by End User (2024-2029) & (USD/Unit)
Table 38. United States Conjunctivitis Sales by Company (2018-2023) & (K Units)
Table 39. United States Conjunctivitis Sales Market Share by Company (2018-2023)
Table 40. United States Conjunctivitis Revenue by Company (2018-2023) & (US$ Million)
Table 41. United States Conjunctivitis Revenue Market Share by Company (2018-2023)
Table 42. United States Conjunctivitis Sales by Type (2018-2023) & (K Units)
Table 43. United States Conjunctivitis Sales Market Share by Type (2018-2023)
Table 44. United States Conjunctivitis Sales by Type (2024-2029) & (K Units)
Table 45. United States Conjunctivitis Sales Market Share by Type (2024-2029)
Table 46. United States Conjunctivitis Sales by End User (2018-2023) & (K Units)
Table 47. United States Conjunctivitis Sales Market Share by End User (2018-2023)
Table 48. United States Conjunctivitis Sales by End User (2024-2029) & (K Units)
Table 49. United States Conjunctivitis Sales Market Share by End User (2024-2029)
Table 50. Europe Conjunctivitis Sales by Company (2018-2023) & (K Units)
Table 51. Europe Conjunctivitis Sales Market Share by Company (2018-2023)
Table 52. Europe Conjunctivitis Revenue by Company (2018-2023) & (US$ Million)
Table 53. Europe Conjunctivitis Revenue Market Share by Company (2018-2023)
Table 54. Europe Conjunctivitis Sales by Type (2018-2023) & (K Units)
Table 55. Europe Conjunctivitis Sales Market Share by Type (2018-2023)
Table 56. Europe Conjunctivitis Sales by Type (2024-2029) & (K Units)
Table 57. Europe Conjunctivitis Sales Market Share by Type (2024-2029)
Table 58. Europe Conjunctivitis Sales by End User (2018-2023) & (K Units)
Table 59. Europe Conjunctivitis Sales Market Share by End User (2018-2023)
Table 60. Europe Conjunctivitis Sales by End User (2024-2029) & (K Units)
Table 61. Europe Conjunctivitis Sales Market Share by End User (2024-2029)
Table 62. China Conjunctivitis Sales by Company (2018-2023) & (K Units)
Table 63. China Conjunctivitis Sales Market Share by Company (2018-2023)
Table 64. China Conjunctivitis Revenue by Company (2018-2023) & (US$ Million)
Table 65. China Conjunctivitis Revenue Market Share by Company (2018-2023)
Table 66. China Conjunctivitis Sales by Type (2018-2023) & (K Units)
Table 67. China Conjunctivitis Sales Market Share by Type (2018-2023)
Table 68. China Conjunctivitis Sales by Type (2024-2029) & (K Units)
Table 69. China Conjunctivitis Sales Market Share by Type (2024-2029)
Table 70. China Conjunctivitis Sales by End User (2018-2023) & (K Units)
Table 71. China Conjunctivitis Sales Market Share by End User (2018-2023)
Table 72. China Conjunctivitis Sales by End User (2024-2029) & (K Units)
Table 73. China Conjunctivitis Sales Market Share by End User (2024-2029)
Table 74. Japan Conjunctivitis Sales by Company (2018-2023) & (K Units)
Table 75. Japan Conjunctivitis Sales Market Share by Company (2018-2023)
Table 76. Japan Conjunctivitis Revenue by Company (2018-2023) & (US$ Million)
Table 77. Japan Conjunctivitis Revenue Market Share by Company (2018-2023)
Table 78. Japan Conjunctivitis Sales by Type (2018-2023) & (K Units)
Table 79. Japan Conjunctivitis Sales Market Share by Type (2018-2023)
Table 80. Japan Conjunctivitis Sales by Type (2024-2029) & (K Units)
Table 81. Japan Conjunctivitis Sales Market Share by Type (2024-2029)
Table 82. Japan Conjunctivitis Sales by End User (2018-2023) & (K Units)
Table 83. Japan Conjunctivitis Sales Market Share by End User (2018-2023)
Table 84. Japan Conjunctivitis Sales by End User (2024-2029) & (K Units)
Table 85. Japan Conjunctivitis Sales Market Share by End User (2024-2029)
Table 86. Southeast Asia Conjunctivitis Sales by Company (2018-2023) & (K Units)
Table 87. Southeast Asia Conjunctivitis Sales Market Share by Company (2018-2023)
Table 88. Southeast Asia Conjunctivitis Revenue by Company (2018-2023) & (US$ Million)
Table 89. Southeast Asia Conjunctivitis Revenue Market Share by Company (2018-2023)
Table 90. Southeast Asia Conjunctivitis Sales by Type (2018-2023) & (K Units)
Table 91. Southeast Asia Conjunctivitis Sales Market Share by Type (2018-2023)
Table 92. Southeast Asia Conjunctivitis Sales by Type (2024-2029) & (K Units)
Table 93. Southeast Asia Conjunctivitis Sales Market Share by Type (2024-2029)
Table 94. Southeast Asia Conjunctivitis Sales by End User (2018-2023) & (K Units)
Table 95. Southeast Asia Conjunctivitis Sales Market Share by End User (2018-2023)
Table 96. Southeast Asia Conjunctivitis Sales by End User (2024-2029) & (K Units)
Table 97. Southeast Asia Conjunctivitis Sales Market Share by End User (2024-2029)
Table 98. India Conjunctivitis Sales by Company (2018-2023) & (K Units)
Table 99. India Conjunctivitis Sales Market Share by Company (2018-2023)
Table 100. India Conjunctivitis Revenue by Company (2018-2023) & (US$ Million)
Table 101. India Conjunctivitis Revenue Market Share by Company (2018-2023)
Table 102. India Conjunctivitis Sales by Type (2018-2023) & (K Units)
Table 103. India Conjunctivitis Sales Market Share by Type (2018-2023)
Table 104. India Conjunctivitis Sales by Type (2024-2029) & (K Units)
Table 105. India Conjunctivitis Sales Market Share by Type (2024-2029)
Table 106. India Conjunctivitis Sales by End User (2018-2023) & (K Units)
Table 107. India Conjunctivitis Sales Market Share by End User (2018-2023)
Table 108. India Conjunctivitis Sales by End User (2024-2029) & (K Units)
Table 109. India Conjunctivitis Sales Market Share by End User (2024-2029)
Table 110. Novartis (CH) Corporation Information
Table 111. Novartis (CH) Description and Business Overview
Table 112. Novartis (CH) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Novartis (CH) Conjunctivitis Product
Table 114. Novartis (CH) Recent Development
Table 115. Santen Pharmaceutical (JP) Corporation Information
Table 116. Santen Pharmaceutical (JP) Description and Business Overview
Table 117. Santen Pharmaceutical (JP) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Santen Pharmaceutical (JP) Conjunctivitis Product
Table 119. Santen Pharmaceutical (JP) Recent Development
Table 120. Bausch & Lomb (US) Corporation Information
Table 121. Bausch & Lomb (US) Description and Business Overview
Table 122. Bausch & Lomb (US) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Bausch & Lomb (US) Conjunctivitis Product
Table 124. Bausch & Lomb (US) Recent Development
Table 125. Allergan (US) Corporation Information
Table 126. Allergan (US) Description and Business Overview
Table 127. Allergan (US) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. Allergan (US) Conjunctivitis Product
Table 129. Allergan (US) Recent Development
Table 130. Sun Pharmaceutical (ID) Corporation Information
Table 131. Sun Pharmaceutical (ID) Description and Business Overview
Table 132. Sun Pharmaceutical (ID) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Sun Pharmaceutical (ID) Conjunctivitis Product
Table 134. Sun Pharmaceutical (ID) Recent Development
Table 135. Akorn (US) Corporation Information
Table 136. Akorn (US) Description and Business Overview
Table 137. Akorn (US) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Akorn (US) Conjunctivitis Product
Table 139. Akorn (US) Recent Development
Table 140. Freda (CN) Corporation Information
Table 141. Freda (CN) Description and Business Overview
Table 142. Freda (CN) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. Freda (CN) Conjunctivitis Product
Table 144. Freda (CN) Recent Development
Table 145. Sinqi (CN) Corporation Information
Table 146. Sinqi (CN) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 147. Sinqi (CN) Description and Business Overview
Table 148. Sinqi (CN) Conjunctivitis Product
Table 149. Sinqi (CN) Recent Development
Table 150. Univision (CN) Corporation Information
Table 151. Univision (CN) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 152. Univision (CN) Description and Business Overview
Table 153. Univision (CN) Conjunctivitis Product
Table 154. Univision (CN) Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Conjunctivitis Distributors List
Table 158. Conjunctivitis Customers List
Table 159. Conjunctivitis Market Trends
Table 160. Conjunctivitis Market Drivers
Table 161. Conjunctivitis Market Challenges
Table 162. Conjunctivitis Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Conjunctivitis Product Picture
Figure 2. Global Conjunctivitis Sales (US$ Million) by Type (2018 & 2022 & 2029)
Figure 3. Global Conjunctivitis Sales Market Share by Type in 2022 & 2029
Figure 4. Antibiotic Product Picture
Figure 5. Pills Product Picture
Figure 6. Ointment Product Picture
Figure 7. Global Conjunctivitis Sales (US$ Million) by End User (2018 & 2022 & 2029)
Figure 8. Global Conjunctivitis Sales Market Share by End User in 2022 & 2029
Figure 9. Newborns Examples
Figure 10. Children Examples
Figure 11. Adults Examples
Figure 12. Global Conjunctivitis Sales, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Conjunctivitis Sales Growth Rate (2018-2029) & (US$ Million)
Figure 14. Global Conjunctivitis Sales (K Units) Growth Rate (2018-2029)
Figure 15. Global Conjunctivitis Price Trends Growth Rate (2018-2029) & (USD/Unit)
Figure 16. Global Market Conjunctivitis Market Size (US$ Million) by Region:2018 VS 2022 VS 2029
Figure 17. Global Conjunctivitis Revenue Market Share by Region: 2018 VS 2022
Figure 18. United States Conjunctivitis Revenue (US$ Million) Growth Rate (2018-2029)
Figure 19. United States Conjunctivitis Sales (K Units) Growth Rate (2018-2029)
Figure 20. Europe Conjunctivitis Revenue (US$ Million) Growth Rate (2018-2029)
Figure 21. Europe Conjunctivitis Sales (US$ Million) Growth Rate (2018-2029)
Figure 22. China Conjunctivitis Revenue (US$ Million) Growth Rate (2018-2029)
Figure 23. China Conjunctivitis Sales (US$ Million) and Growth Rate (2018-2029)
Figure 24. Japan Conjunctivitis Revenue (US$ Million) Growth Rate (2018-2029)
Figure 25. Japan Conjunctivitis Sales (US$ Million) Growth Rate (2018-2029)
Figure 26. Southeast Asia Conjunctivitis Revenue (US$ Million) Growth Rate (2018-2029)
Figure 27. Southeast Asia Conjunctivitis Sales (US$ Million) Growth Rate (2018-2029)
Figure 28. India Conjunctivitis Revenue (US$ Million) Growth Rate (2018-2029)
Figure 29. India Conjunctivitis Sales (US$ Million) Growth Rate (2018-2029)
Figure 30. Global 5 Largest Conjunctivitis Players Market Share by Revenue in Conjunctivitis: 2018 & 2022
Figure 31. Conjunctivitis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 32. Global Conjunctivitis Revenue Share by Type (2018-2023)
Figure 33. Global Conjunctivitis Sales Share by Type (2024-2029)
Figure 34. Global Conjunctivitis Revenue Share by Type (2024-2029)
Figure 35. Global Conjunctivitis Revenue Share by End User (2018-2023)
Figure 36. Global Conjunctivitis Revenue Growth Rate by End User in 2018 & 2022
Figure 37. Global Conjunctivitis Sales Share by End User (2024-2029)
Figure 38. Global Conjunctivitis Revenue Share by End User (2024-2029)
Figure 39. Key Raw Materials Price Trend
Figure 40. Manufacturing Cost Structure of Conjunctivitis
Figure 41. Manufacturing Process Analysis of Conjunctivitis
Figure 42. Conjunctivitis Industrial Chain Analysis
Figure 43. Channels of Distribution
Figure 44. Distributors Profiles
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed
  • Global Artificial Tears Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 91
    Artificial tears are lubricant eye drops used to treat The dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca (dry eyes). They are also used to moisten contact lenses and in eye examinations. The global Artificial Tears market was valued at US$ 2921.6 million in 2023 and is anticipated to reach US$ 5240.1 million by 2030, witnessing a CAGR of 8.6% during The forecast period 2024-2030. The industry's leading producers are Aller......
  • Global Contact Lens Solution Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 96
    Contact lens solution is a kind of solution that is used to contact lens with The function of cleaning, disinfection, rinsing or preservation, it can also alleviate The eyeball discomfort which caused by wear The contact lens. Contact lens solution can direct contact eyeball, so it must be accord with industrial standard. The global Contact Lens Solution market was valued at US$ 4087.6 million in 2023 and is anticipated to reach US$ 5323.5 million by 2030, witnessing a CAGR of 3.8% ......
  • Global Latanoprost Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 82
    Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside The eye. Onset of effects is usually within four hours, and they last for up to a day. Latanoprost is used to treat high pressure inside The eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in The body (prostaglandin) and works by regulating The flow of fluid within The eye which results in lower pressure. Lowerin......
  • Global Contact Lens Solution Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 99
    Market Overview of Global Contact Lens Solution market: According to our latest research, the global Contact Lens Solution market looks promising in the next 5 years. As of 2022, the global Contact Lens Solution market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Contact ......
  • Global Dry Eye Syndrome Drugs Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The Dry Eye Syndrome Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dry Eye Syndrome Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive......
  • Global Eye Drops & Lubricants Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112
    According to our LPI (LP Information) latest study, the global Eye Drops & Lubricants market size was valued at US$ 8841.8 million in 2023. With growing demand in downstream market, the Eye Drops & Lubricants is forecast to a readjusted size of US$ 9780.8 million by 2030 with a CAGR of 1.5% during review period. The research report highlights the growth potential of the global Eye Drops & Lubricants market. Eye Drops & Lubricants are expected to show stable growth in the future market. H......
  • Global Conjunctivitis Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 98
    According to our LPI (LP Information) latest study, the global Conjunctivitis market size was valued at US$ 3482.7 million in 2023. With growing demand in downstream market, the Conjunctivitis is forecast to a readjusted size of US$ 3908 million by 2030 with a CAGR of 1.7% during review period. The research report highlights the growth potential of the global Conjunctivitis market. Conjunctivitis are expected to show stable growth in the future market. However, product differentiation, r......
  • Global Contact Lens Solution Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 118
    According to our LPI (LP Information) latest study, the global Contact Lens Solution market size was valued at US$ 3998.7 million in 2023. With growing demand in downstream market, the Contact Lens Solution is forecast to a readjusted size of US$ 5241.5 million by 2030 with a CAGR of 3.9% during review period. The research report highlights the growth potential of the global Contact Lens Solution market. Contact Lens Solution are expected to show stable growth in the future market. Howev......
  • Global Latanoprost Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Latanoprost market size was valued at US$ 1344.2 million in 2023. With growing demand in downstream market, the Latanoprost is forecast to a readjusted size of US$ 1574.2 million by 2030 with a CAGR of 2.3% during review period. The research report highlights the growth potential of the global Latanoprost market. Latanoprost are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs